Synthesis and Characterization of Naphthalenediimide-Functionalized Flavin Derivatives

Two acceptor–acceptor dyads have been synthesized featuring a flavin moiety and a naphthalenediimide (NDI) unit. The NDI unit is linked to the flavin through a short spacer group via either the N(3) or N(10) positions of the flavin. We have investigated the UV-Vis and redox properties of these multi-electron accepting systems which indicate that these materials display the collective properties of their component systems. Fluorescence spectroscopy measurements have revealed that their emission properties are dominated by the flavin unit

Redox-mediated reactions of vinylferrocene: Toward redox auxiliaries

Chemical redox reactions have been exploited to transform unreactive vinylferrocene into a powerful dienophile for the Diels–Alder reaction and reactive substrate for thiol addition reactions upon conversion to its ferrocenium state. We have further investigated the ability of these reactions to facilitate redox-auxiliary-like reactivity by further hydrogenolyisis of the Diels–Alder adduct to the corresponding cyclopentane derivative

Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set

PMID: 22290396 [PubMed] PMCID: PMC3269047 Free PMC ArticlePeer reviewedPublisher PD

Correction: Zainalabdeen, N., et al., Synthesis and Characterization of Naphthalenediimide-Functionalized Flavin Derivatives. Int. J. Mol. Sci. 2013, 14, 7468–7479.

Note: In lieu of an abstract, this is an excerpt from the first page. In the original version of the manuscript [1] some of the analytical data for compounds 1 and 2 were incorrect. The correct NMR data are presented below. The authors apologize for any inconvenience this may have caused to the readers of this journal. Compound 1: 1H NMR (500 MHz, DMSO-d6) δ 11.64 (s, 1H), 8.73 (s, 4H), 8.57 (d, J = 1.4 Hz, 1H), 8.16 (dd, J = 8.9, 1.4 Hz, 1H), 7.81 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 6.99 (d, J = 8.9 Hz, 1H), 4.08 (t, J = 7.0 Hz, 2H), 3.28 (m, 2H), 1.69 (quin, J = 7.0 Hz, 2H), 1.33 (m, 8H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, DMSO-d6) δ 162.6 (2xC = 0), 162.3 (2xC = 0), 158.9, 155.1, 151.9, 140.8, 136.6, 136.1, 135.2, 133.7, 131.1 (2xC), 130.5 (4xC), 130.3 (q, J = 4 Hz), 128.6 (q, J = 4 Hz), 128.4 (2xC), 126.6, 126.5 (2xC), 126.4 (q, J = 31 Hz), 126.3 (2xC), 126.2, 123.2 (q, J = 271 Hz), 117.8, 39.9, 30.9, 28.5, 28.3, 27.1, 26.3, 21.9, 13.7. Compound 2: 1H NMR (500 MHz, CDCl3) δ 8.77 (s, 4H), 8.58 (d, J = 1.4 Hz, 1H), 8.03 (dd, J = 9.1, 1.4 Hz, 1H), 7.87 (d, J = 8.4 Hz, 2H), 7.76 (d, J = 9.1 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 5.37 (s, 2H), 4.61 (br s, 2H), 4.19 (t, 2H), 2.47 (sept, J = 6.7 Hz, 1H), 1.74 (m, 2H), 1.47–1.23 (m, 10H), 1.07 (d, J = 6.7 Hz, 6H), 0.87 (t, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 163.1 (2xC = O), 162.9 (2xC = O), 159.0, 155.0, 149.9, 138.9, 137.5, 135.2, 134.9, 134.3, 131.7 (2xC), 131.5 (2xC), 131.2 (q, J = 4 Hz), 131.1 (4xC), 130.9 (q, J = 4 Hz), 128.6 (2xC), 127.1 (2xC), 127.0 (q, J = 28 Hz), 126.8 (2xC), 123.1 (q, J = 270 Hz), 116.9, 51.5, 44.9, 41.2, 31.9, 29.4, 29.3, 28.2, 27.6, 27.2, 22.8, 20.2 (2xC), 14.2

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses : the Knee Arthroplasty Trial (KAT)

Peer reviewedPublisher PD

The Knee Arthroplasty Trial (KAT) : design features, baseline characteristics and two-year functional outcomes after alternative approaches to knee replacement

Background: The aim of continued development of total knee replacement systems has been the further improvement of the quality of life and increasing the duration of prosthetic survival. Our goal was to evaluate the effects of several design features, including metal backing of the tibial component, patellar resurfacing, and a mobile bearing between the tibial and femoral components, on the function and survival of the implant. Methods: A pragmatic, multicenter, randomized, controlled trial involving 116 surgeons in thirty-four centers in the United Kingdom was performed; 2352 participants were randomly allocated to be treated with or without a metal backing of the tibial component (409), with or without patellar resurfacing (1715), and/or with or without a mobile bearing (539). Randomization to more than one comparison was allowed. The primary outcome measures were the Oxford Knee Score (OKS), Short Form-12, EuroQol-5D, and the need for additional surgery. The results up to two years postoperatively are reported. Results: Functional status and quality-of-life scores were low at baseline but improved markedly across all trial groups following knee replacement (mean overall OKS, 17.98 points at baseline and 34.82 points at two years). Most of the change was observed at three months after the surgery. Six percent of the patients had additional knee surgery within two years. There was no evidence of differences in clinical, functional, or quality-of-life measures between the randomized groups at two years. Conclusions: Patients have substantial improvement following total knee replacement. This is the first adequately powered randomized controlled trial, of which we are aware, in which the effects of metal backing, patellar resurfacing, and a mobile bearing were investigated. We found no evidence of an effect of these variants on the rate of early complications or on functional recovery up to two years after total knee replacement. Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.NIHR Health Technology Assessment Programme (Project Number 95/10/01); Howmedica Osteonics; Zimmer; DePuy, a Johnson and Johnson company; Corin Medical; Smith and Nephew Healthcare. Biomet Merck; and Wright CremascoliPeer reviewe

Facile synthesis of metal-free organic dyes featuring a thienylethynyl spacer for dye sensitized solar cells

In this article, we report the facile synthesis of metal-free dyes 6 and 7, their solution-based optical and redox properties and their use as sensitizers in dye-sensitized solar cells (DSSCs). Our studies indicate that the addition of the second thiophene unit in dye 7, decreases the oxidation and reduction potential and consequently the band gap of the molecule compared to 6. Furthermore, increasing the length of the conjugated spacer also affects on the properties of the DSSCs, with dye 7 providing a higher power conversion efficiency compared to 6 (η = 4.49 versus 3.23%)

Increased dolutegravir peak concentrations in people living with HIV aged 60 and over and analysis of sleep quality and cognition

Background Demographic data show an increasingly aging HIV population worldwide. Recent concerns over dolutegravir-related neuropsychiatric toxicity have emerged, particularly amongst older HIV patients. We describe the pharmacokinetics (PK) of dolutegravir (DTG) 50mg once daily in people living with HIV (PLWH) aged 60 and older. Additionally, to address the call for prospective neuropsychiatric toxicodynamic data, we evaluate changes in sleep quality and cognitive function after switching to abacavir (ABC)/lamivudine (3TC)/DTG, over 6 months in this population. Methods PLWH aged≥60years with HIV-RNA<50copies/mL on any non-DTG based antiretroviral combination were switched to ABC/3TC/DTG. On day 28, 24-hour PK sampling was undertaken. Steady-state PK parameters were compared to a published historical control population aged≤50years. Six validated sleep questionnaires and neurocognitive (Cogstate®) testing were administered pre-switch and over 180 days (NCT02509195). Results Forty-three participants were enrolled; 40 completed the PK phase. Overall, five discontinued (two due adverse events, both sleep related, 4.6%). DTG maximum concentration (Cmax) was significantly higher in patients≥60 versus controls (GM 4246ng/mL versus 3402ng/mL, p=0.005). In those who completed day 180 (n=38), sleep impairment was higher at day 28 (PSQI median global score 5.0 versus 6.0 p=0.02) but not at day 90 or 180. Insomnia, daytime function, fatigue test scores did not change statistically over time. Conclusion DTG Cmax was significantly higher in older PLWH. Our data provides clinicians with key information on the safety of prescribing DTG in older PLWH

Spectrum monitoring and analysis with the AMD RFSoC

The Radio Frequency (RF) spectrum is a finite resource that requires strict regulation to prevent illegitimate use and unauthorised transmissions. Spectrum monitoring (measurement and analysis) is key to supporting regulation by determining usage and occupancy in real-time as well as establishing temporal trends. Spectrum monitoring technology can also enable Dynamic Spectrum Access (DSA) solutions, which improve the efficiency of the radio spectrum by autonomously adjusting wireless communication networks in real-time. DSA techniques require knowledge of real-time spectrum occupancy and a historical database of past usage. Engineers from the University of Strathclyde and Advanced Micro Devices (AMD) have developed an innovative spectrum monitoring solution that aims to improve spectrum regulation and enable real-time DSA techniques. This solution features an open-source software stack and hardware design to measure the power of ambient radio signals and record the frequency spectrum over time. The system is also able to combine spectrum measurements alongside a local database of frequency band allocations published by Ofcom (UK regulator). Thus, the spectrum monitoring solution can identify in-use frequency bands and the organisation(s) that can legitimately use them. The solution is implemented entirely on AMD’s Radio Frequency System on Chip (RFSoC) device, which features high-speed data converters for accurately performing wide-bandwidth measurements of the frequency spectrum. Autonomous vehicles, media and broadcast technologies, and smart manufacturing environments increasingly require DSA to overcome wireless communication congestion. DSA techniques are essential to improve the efficient allocation of the RF spectrum. This spectrum monitoring solution addresses the challenge of implementing DSA techniques by providing a cost-effective, real-time solution for efficiently measuring and recording the ambient radio spectrum. For example, the spectrum monitor can be deployed alongside a 4G/5G mobile base station and can probe the local radio spectrum to inform the base station as to the most suitable frequency bands for wireless communication